Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pulse Biosciences Inc PLSE

Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s proprietary CellFX nsPFA technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is engaged in the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it... see more

Recent & Breaking News (NDAQ:PLSE)

Pulse Biosciences Grants Equity Incentive Awards to New Employees

Business Wire March 21, 2018

Pulse Biosciences Quarterly Investor Conference Call

Business Wire March 16, 2018

Pulse Biosciences, Inc. to Host Earnings Call

Accesswire March 16, 2018

Pulse Biosciences to Report Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights

Business Wire March 8, 2018

Pulse Biosciences Grants Equity Inducement Awards to New Employees

Business Wire December 15, 2017

New Research: Key Drivers of Growth for Synchrony Financial, Pulse Biosciences, Ally Financial, RealPage, Briggs & Stratton, and Genesis Energy — Factors of Influence, Major Initiatives and Sustained Production

GlobeNewswire December 4, 2017

Pulse Biosciences Quarterly Investor Conference Call

Business Wire November 7, 2017

Pulse Biosciences, Inc. to Host Earnings Call

Accesswire November 7, 2017

Pulse Biosciences Announces Transition of Board of Directors, Extends Appreciation to Retiring Members and Welcomes New Board Members

Business Wire November 3, 2017

Detailed Research: Economic Perspectives on Discover Financial, Pulse Biosciences, The Travelers Companies, Xylem, Cheniere Energy Partners, and Cheniere Energy – What Drives Growth in Today's Competitive Landscape

GlobeNewswire November 3, 2017

Pulse Biosciences to Host Quarterly Investor Conference Call on November 7, 2017

Business Wire October 24, 2017

Mid-Afternoon Market Update: Crude Oil Up Over 3%; AZZ Shares Plummet

Benzinga.com  September 25, 2017

Pulse Biosciences Announces $30 Million Private Placement

Business Wire September 25, 2017

12 Biggest Mid-Day Losers For Wednesday

Benzinga.com  September 13, 2017

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Tintri, Inc. -- TNTR

Business Wire September 11, 2017

Glancy Prongay & Murray LLP Commences Investigation on Behalf of Pulse Biosciences, Inc. Investors (PLSE)

Business Wire September 11, 2017

Mid-Day Market Update: Dow Up 1%; Achillion Pharmaceuticals Shares Plunge

Benzinga.com  September 11, 2017

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Health Insurance Innovations, Inc. – HIIQ

Business Wire September 11, 2017

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Tintri, Inc. (TNTR)

PR Newswire September 11, 2017

Pulse Biosciences Announces Withdrawal and Planned Resubmission of 510(k) Application for the PulseTxTM System

Business Wire September 11, 2017